Of cer for Scotland, described how their Con dentiality and Security Advisory Group was established to develop systems that command public and patient con dence, to promote good practice for clinicians and researchers, and to preserve important public health and research functions. The ways in which these same aims have been approached in Canada were highlighted by Don Willison, a health services researcher at McMaster University.
Willison also provides one of several critiques of the approach being advocated and taken in England and Wales. Among the issues he raises is the all important need to recognise the diversity of researchers' interests and, in particular, the contrast between research with commercial interests and that without. Commentaries from four other perspectives follow. P hil Boyd, Assistant Information Commissioner, outlines the key requirements of the 1998 Data Protection Act in the UK and the principal consequences for researchers wanting to use health data. Cyril Chantler, until recently chairman of the General Medical Council's Standards Committee, together with Jane O'Brien, explain that organisation's views of con dentiality and its role in advising doctors. To complement the medical perspective, Harry Cayton and Simon Denegri of the Alzheimer's Society present the patients' view, focusing particularly on the issue of ownership of data and the need to involve patients in the development of policies on data collection and use. Finally, the view of researchers is put forward as a reminder of the uniqueness and the value of the secondary use of clinical data in health research and what would be put at risk if such work were prevented or seriously limited in the future.
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